1. Home
  2. SHIM vs MSLE Comparison

SHIM vs MSLE Comparison

Compare SHIM & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shimmick Corporation

SHIM

Shimmick Corporation

HOLD

Current Price

$3.70

Market Cap

149.2M

Sector

N/A

ML Signal

HOLD

Logo Satellos Bioscience Inc. Common Stock

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$8.90

Market Cap

154.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SHIM
MSLE
Founded
1990
N/A
Country
United States
Canada
Employees
N/A
21
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
149.2M
154.6M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
SHIM
MSLE
Price
$3.70
$8.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
133.6K
77.0K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
81.95
N/A
EPS
N/A
N/A
Revenue
$492,844,000.00
N/A
Revenue This Year
$13.99
N/A
Revenue Next Year
$6.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.63
N/A
52 Week Low
$1.58
$5.44
52 Week High
$6.76
$13.39

Technical Indicators

Market Signals
Indicator
SHIM
MSLE
Relative Strength Index (RSI) 45.83 61.70
Support Level $3.43 $6.71
Resistance Level $4.10 $9.75
Average True Range (ATR) 0.34 0.74
MACD -0.01 0.08
Stochastic Oscillator 17.20 56.54

Price Performance

Historical Comparison
SHIM
MSLE

About SHIM Shimmick Corporation

Shimmick Corp is engaged in delivering turnkey infrastructure solutions that strengthen critical markets across water, energy, climate resiliency, and sustainable transportation. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains critical infrastructure, including mass transit, bridges, and military infrastructure. The company has one operating and reportable segment: infrastructure solutions. All of its revenue is derived from the United States.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: